Navigation Links
Cellular Dynamics International Files Registration Statement for Proposed Initial Public Offering
Date:6/4/2013

MADISON, Wis., June 4, 2013 /PRNewswire/ -- Cellular Dynamics International, Inc., a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced that it has filed a registration statement on June 3, 2013, on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of its common stock. The registration statement filed on June 3, 2013, represents the Company's initial public filing pursuant to the provisions of the Jumpstart Our Business Startups (JOBS) Act of 2012. The common stock is expected to be listed on the NASDAQ Global Market under the symbol "ICEL." The number of shares to be offered and the price range for the offering have not been determined.

J.P. Morgan Securities LLC is acting as the sole book-running manager for the offering. Cowen and Company, LLC and Leerink Swann LLC are acting as co-managers.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the offering may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204


'/>"/>
SOURCE Cellular Dynamics International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
2. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
3. Top Genetic and Cellular Researchers Honored at ASGCT 16th Annual Meeting
4. Exit discovered in cellular garbage truck
5. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
6. Cellular Biomedicine Group Provides Update and 2013 Milestones
7. Unique Extracellular Matrix Used in Patient Successfully Treated for Flesh Eating Bacteria
8. Blood-Based Circulating Microvesicles (cMV) Data to be Presented at the 2013 International Society for Extracellular Vesicles (ISEV)
9. Sigma Life Science and the Culture Collections of Public Health England Collaborate to Distribute Cells and Cellular Extracts
10. Cellular Therapy and Cord Blood 2013 Market Report
11. Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... NEW YORK , Feb. 20, 2017 This ... Thousand by the following Product Types: Xylanase, Amylase, Cellulase, and ... Canada , Japan , ... Latin America , and Rest of World. ... Annual estimates and forecasts are provided for the ...
(Date:2/20/2017)... ... 20, 2017 , ... PuraCath Medical, an emerging company developing ... today that it has published the result of its recent research on its ... the official Journal of the International Society for Peritoneal Dialysis . PDI ...
(Date:2/18/2017)... MONTREAL , February 18, 2017 ... von intrazellulären Zytokinen bei adoptiven Zelltherapie-Studien, Poster legt metaproteomische ... ... Biosciences Inc. heute bekanntgab, wird Dr. Yoav Peretz ... Methoden in der Entwicklung von Assays zum Nachweis intrazellulärer ...
(Date:2/17/2017)... Calif. , Feb. 17, 2017  BioGenex, ... to announce development of a novel system for ... collaboration with the University of Rochester (NY, USA) ... ). The new system is able to accurately ... biomarker, HER2 (Human epidermal growth factor receptor-2) in ...
Breaking Biology Technology:
(Date:2/2/2017)... TOKYO , Feb. 1, 2017  Central ... innovative and meaningful advances worldwide, The Japan Prize ... Japan Prize, who have pushed the envelope in ... Information and Communication. Three scientists are being recognized ... outstanding achievements that not only contribute to the ...
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements ... Management (IAM) lifecycle is comprised of a comprehensive ... the purpose of maintaining digital identities and providing ... and applications. There are significant number of programs ... time to time by optimizing processes and changing ...
Breaking Biology News(10 mins):